Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 290

1.

SMARCA4 Loss is Very Rare in Thoracic Mesothelioma.

Ahadi MS, Gill AJ.

Am J Surg Pathol. 2019 Apr 23. doi: 10.1097/PAS.0000000000001262. [Epub ahead of print] No abstract available.

PMID:
31021854
2.

High-grade Oncocytic Tumor (HOT) of Kidney in a Patient with Tuberous Sclerosis Complex.

Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O.

Histopathology. 2019 Apr 19. doi: 10.1111/his.13876. [Epub ahead of print]

PMID:
31002177
3.

RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma.

Joo LJS, Weiss J, Gill AJ, Clifton-Bligh R, Brahmbhatt H, MacDiarmid JA, Gild ML, Robinson BG, Zhao JT, Sidhu SB.

Thyroid. 2019 May 9. doi: 10.1089/thy.2018.0525. [Epub ahead of print]

PMID:
30929576
4.

microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.

Kwok GTY, Zhao JT, Glover AR, Gill AJ, Clifton-Bligh R, Robinson BG, Ip JCY, Sidhu SB.

Oncologist. 2019 Mar 27. pii: theoncologist.2018-0849. doi: 10.1634/theoncologist.2018-0849. [Epub ahead of print]

PMID:
30918109
5.

Australasian Gastrointestinal Pathology Society (AGPS) consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma.

Yozu M, Kumarasinghe MP, Brown IS, Gill AJ, Rosty C.

Pathology. 2019 Apr;51(3):233-239. doi: 10.1016/j.pathol.2018.11.014. Epub 2019 Mar 6.

PMID:
30851981
6.

Androgen receptor immunoexpression in triple-negative breast cancers: is it a prognostic factor?

Zaborowski M, Pearson A, Sioson L, Gill AJ, Ahadi MS.

Pathology. 2019 Apr;51(3):327-329. doi: 10.1016/j.pathol.2018.09.063. Epub 2019 Mar 5. No abstract available.

PMID:
30846226
7.

SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.

Schlichtemeier SM, Nahm CB, Xue A, Gill AJ, Smith RC, Hugh TJ.

J Surg Res. 2019 Jun;238:127-136. doi: 10.1016/j.jss.2019.01.008. Epub 2019 Feb 13.

PMID:
30771682
8.

MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.

Gill P, Kim E, Chua TC, Clifton-Bligh RJ, Nahm CB, Mittal A, Gill AJ, Samra JS.

Endocr Pathol. 2019 Feb 14. doi: 10.1007/s12022-019-9570-y. [Epub ahead of print]

PMID:
30767148
9.

Management of post-pancreatectomy haemorrhage using resuscitative endovascular balloon occlusion of the aorta.

Singh G, Nahm CB, Jamieson NB, Chua TC, Wong S, Thoo C, Mittal A, Gill AJ, Samra JS.

Langenbecks Arch Surg. 2019 Mar;404(2):253-255. doi: 10.1007/s00423-019-01759-0. Epub 2019 Feb 13.

PMID:
30758668
10.

Revisiting the Significance of Prominent C Cells in the Thyroid.

Fuchs TL, Bell SE, Chou A, Gill AJ.

Endocr Pathol. 2019 Jan 29. doi: 10.1007/s12022-019-9567-6. [Epub ahead of print]

PMID:
30694510
11.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
12.

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

Pinho AV, Van Bulck M, Chantrill L, Arshi M, Sklyarova T, Herrmann D, Vennin C, Gallego-Ortega D, Mawson A, Giry-Laterriere M, Magenau A, Leuckx G, Baeyens L, Gill AJ, Phillips P, Timpson P, Biankin AV, Wu J, Rooman I.

Nat Commun. 2018 Nov 30;9(1):5083. doi: 10.1038/s41467-018-07497-z.

13.

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.

Parkin A, Man J, Chou A, Nagrial AM, Samra J, Gill AJ, Timpson P, Pajic M.

Diseases. 2018 Nov 13;6(4). pii: E103. doi: 10.3390/diseases6040103. Review.

14.

Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy.

Nahm CB, Lui I, Naidoo CS, Roseverne L, Alzaabi S, Maher R, Mann G, Blome S, Gill AJ, Samra JS, Mittal A.

HPB (Oxford). 2019 May;21(5):604-611. doi: 10.1016/j.hpb.2018.09.014. Epub 2018 Oct 28.

PMID:
30377050
15.

Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.

Nahm CB, Turchini J, Jamieson N, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A.

Eur J Surg Oncol. 2019 Feb;45(2):218-224. doi: 10.1016/j.ejso.2018.10.050. Epub 2018 Oct 11.

PMID:
30348604
16.

Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.

Shyu I, Mirsadraei L, Wang X, Robila V, Mehra R, McHugh JB, Chen YB, Udager AM, Gill AJ, Cheng L, Amin MB, Lin O, Smith SC.

Cancer Cytopathol. 2018 Dec;126(12):992-1002. doi: 10.1002/cncy.22071. Epub 2018 Oct 19.

PMID:
30339328
17.

"High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.

He H, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ, Tretiakova M, Lopez JI, Williamson SR, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Pivovarcikova K, Michalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O.

Virchows Arch. 2018 Dec;473(6):725-738. doi: 10.1007/s00428-018-2456-4. Epub 2018 Sep 19.

PMID:
30232607
18.

Bayesian approach to determining penetrance of pathogenic SDH variants.

Benn DE, Zhu Y, Andrews KA, Wilding M, Duncan EL, Dwight T, Tothill RW, Burgess J, Crook A, Gill AJ, Hicks RJ, Kim E, Luxford C, Marfan H, Richardson AL, Robinson B, Schlosberg A, Susman R, Tacon L, Trainer A, Tucker K, Maher ER, Field M, Clifton-Bligh RJ.

J Med Genet. 2018 Nov;55(11):729-734. doi: 10.1136/jmedgenet-2018-105427. Epub 2018 Sep 10.

19.

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.

Chou A, Itchins M, de Reuver PR, Arena J, Clarkson A, Sheen A, Sioson L, Cheung V, Perren A, Nahm C, Mittal A, Samra JS, Pajic M, Gill AJ.

Hum Pathol. 2018 Dec;82:249-257. doi: 10.1016/j.humpath.2018.07.032. Epub 2018 Aug 3.

PMID:
30081149
20.

Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.

Gild ML, Tsang V, Samra J, Clifton-Bligh RJ, Tacon L, Gill AJ.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3119-3123. doi: 10.1210/jc.2018-01074.

PMID:
30032256

Supplemental Content

Loading ...
Support Center